Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Pedersen-Bjergaard

Showing results (41-50 of 100) with videos related to

Pageof 10
Sort By:
Blood|November 1, 1995
Different genetic pathways in leukemogenesis for patients presenting with therapy-related myelodysplasia and therapy-related acute myeloid leukemiaJ Pedersen-Bjergaard, M Pedersen, D Roulston, et al.
Ugeskrift for Laeger|August 7, 1978
[Hairy cell leukemia--leukemic reticuloendotheliosis. A review of literature and a case report]H Schultz, J Pedersen-Bjergaard, H Tinggård, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1995
Leiomyosarcoma of the urinary bladder after cyclophosphamideJ Pedersen-Bjergaard, V Jønsson, M Pedersen, et al.
Scandinavian Journal of Haematology|November 1, 1979
Phase II trial of Prednimustine. Leo-1031 (NSC-134087) in acute non-lymphocytic leukemiaK Juul, P Sørensen, J Pedersen-Bjergaard, et al.
Leukemia|September 26, 1997
Chemotherapy-related - late occurring - Philadelphia chromosome in AML, ALL and CML. Similar events related to treatment with DNA topoisomerase II inhibitors?J Pedersen-Bjergaard, K Brøndum-Nielsen, H Karle, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1985
Leukemia following treatment of germ cell tumors in menJ Pedersen-Bjergaard, M Rørth, N I Nissen, et al.
Leukemia|October 26, 2002
Causality of myelodysplasia and acute myeloid leukemia and their genetic abnormalitiesJ Pedersen-Bjergaard, D H Christiansen, M K Andersen, et al.
Genes, Chromosomes & Cancer|April 3, 2001
Duplication or amplification of chromosome band 11q23, including the unrearranged MLL gene, is a recurrent abnormality in therapy-related MDS and AML, and is closely related to mutation of the TP53 gene and to previous therapy with alkylating agentsM K Andersen, D H Christiansen, M Kirchhoff, et al.
Haematologica|July 24, 1998
Chromosomal abnormalities in secondary MDS and AML. Relationship to drugs and radiation with specific emphasis on the balanced rearrangementsM K Andersen, B Johansson, S O Larsen, et al.
Leukemia|September 23, 2006
Alternative genetic pathways and cooperating genetic abnormalities in the pathogenesis of therapy-related myelodysplasia and acute myeloid leukemiaJ Pedersen-Bjergaard, D H Christiansen, F Desta, et al.
Pageof 10

Showing results (41-50 of 100) with videos related to

Sort By:
Pageof 10
Blood|November 1, 1995
Different genetic pathways in leukemogenesis for patients presenting with therapy-related myelodysplasia and therapy-related acute myeloid leukemiaJ Pedersen-Bjergaard, M Pedersen, D Roulston, et al.
Ugeskrift for Laeger|August 7, 1978
[Hairy cell leukemia--leukemic reticuloendotheliosis. A review of literature and a case report]H Schultz, J Pedersen-Bjergaard, H Tinggård, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1995
Leiomyosarcoma of the urinary bladder after cyclophosphamideJ Pedersen-Bjergaard, V Jønsson, M Pedersen, et al.
Scandinavian Journal of Haematology|November 1, 1979
Phase II trial of Prednimustine. Leo-1031 (NSC-134087) in acute non-lymphocytic leukemiaK Juul, P Sørensen, J Pedersen-Bjergaard, et al.
Leukemia|September 26, 1997
Chemotherapy-related - late occurring - Philadelphia chromosome in AML, ALL and CML. Similar events related to treatment with DNA topoisomerase II inhibitors?J Pedersen-Bjergaard, K Brøndum-Nielsen, H Karle, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1985
Leukemia following treatment of germ cell tumors in menJ Pedersen-Bjergaard, M Rørth, N I Nissen, et al.
Leukemia|October 26, 2002
Causality of myelodysplasia and acute myeloid leukemia and their genetic abnormalitiesJ Pedersen-Bjergaard, D H Christiansen, M K Andersen, et al.
Genes, Chromosomes & Cancer|April 3, 2001
Duplication or amplification of chromosome band 11q23, including the unrearranged MLL gene, is a recurrent abnormality in therapy-related MDS and AML, and is closely related to mutation of the TP53 gene and to previous therapy with alkylating agentsM K Andersen, D H Christiansen, M Kirchhoff, et al.
Haematologica|July 24, 1998
Chromosomal abnormalities in secondary MDS and AML. Relationship to drugs and radiation with specific emphasis on the balanced rearrangementsM K Andersen, B Johansson, S O Larsen, et al.
Leukemia|September 23, 2006
Alternative genetic pathways and cooperating genetic abnormalities in the pathogenesis of therapy-related myelodysplasia and acute myeloid leukemiaJ Pedersen-Bjergaard, D H Christiansen, F Desta, et al.
Pageof 10